
Life sciences investment arm of Blackstone funding pharmaceutical, biotech and medical technology companies

Tokyo investment firm managing funds and supporting technology commercialisation and overseas expansion

Japan Strategic Capital Co., Ltd. is an investment company that puts money into companies and technologies whose value is not yet widely recognised. It works alongside entrepreneurs and researchers. The team describes itself as bridging Japanese resources with other parts of the world.
The firm helps Japanese companies and technologies go global, and brings foreign companies and technologies into Japan. Recent deals include an investment in Chekkit, a Nigerian company that uses blockchain to fight counterfeit goods.
Summary written by TrustList from the business's own published information, Oct 2026.
2 images - click to enlarge
Japan Strategic Capital is ranked on 2 TrustList rankings: #9 on 1 and #16 on 1.
Every ranking orders its listings by their reviews, how complete the profile is and the Trust Score. Japan Strategic Capital has no reviews yet and 3 of the 10 profile details we look for. Where no listing on a page has been reviewed, the order follows the profiles alone.
It is the only one of the 15 here listing agritech and authentication.
Its profile: “Japan Strategic Capital Co., Ltd.”
Of the 15 here, 7 also cover partners and 4 also cover partnership; 5 also work in Tokyo and 4 also work in San Francisco.
Behind Dreamers VC, ahead of Next Web Capital.
It is the only one of the 23 here listing blockchain and collaboration.
Of the 23 here, 6 also cover agriculture and 4 also cover deep tech; 4 also work in Paris and 3 also work in London.
Behind Invest Northern Ireland, ahead of Mobile Foundation Ventures.
As of 2026-11-01. Organic ranks only; sponsored placements are never ranks. How TrustList ranks
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Japan Strategic Capital.
Similar listings buyers compare against this one.

Life sciences investment arm of Blackstone funding pharmaceutical, biotech and medical technology companies

Oslo-based private investment company backing early and later-stage life science businesses

Healthcare venture fund backed by Blue Cross Blue Shield plans, investing in emerging health companies

Seed-only venture firm backing engineering-minded founders with equity or SAFE investments

Early-stage venture fund backing seed and Series A founders in the US and Europe

Hong Kong investment group backing fintech and technology companies worldwide with hands-on support
Everything here links back to the same verified catalogue. Pick your next stop.